0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.24%
Negative revenue growth while 0360.HK stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-24.76%
Negative gross profit growth while 0360.HK is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
46.87%
EBIT growth of 46.87% while 0360.HK is zero. Bruce Berkowitz would see if small gains can be scaled further.
46.87%
Operating income growth of 46.87% while 0360.HK is zero. Bruce Berkowitz would see if this modest edge can become significant.
-112.51%
Negative net income growth while 0360.HK stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-112.61%
Negative EPS growth while 0360.HK is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-114.85%
Negative diluted EPS growth while 0360.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.05%
Share reduction while 0360.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-14.84%
Reduced diluted shares while 0360.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-146.12%
Negative OCF growth while 0360.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-96.66%
Negative FCF growth while 0360.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-33.83%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-41.53%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-33.91%
Negative 3Y CAGR while 0360.HK stands at 0.55%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-2026.74%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-330.94%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-107.08%
Negative 3Y OCF/share CAGR while 0360.HK stands at 135.34%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-102.98%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-105.81%
Negative 5Y net income/share CAGR while 0360.HK is 38.23%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-104.20%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
631.56%
Positive growth while 0360.HK is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
14.54%
Positive 5Y equity/share CAGR while 0360.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
19.89%
3Y equity/share CAGR at 75-90% of 0360.HK's 22.93%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
-92.85%
Cut dividends over 10 years while 0360.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-19.58%
Negative 5Y dividend/share CAGR while 0360.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-39.20%
Negative near-term dividend growth while 0360.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-22.12%
Firm’s AR is declining while 0360.HK shows 171.75%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
23.92%
We show growth while 0360.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-8.19%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.51%
BV/share growth of 1.51% while 0360.HK is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
38.08%
We have some new debt while 0360.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-67.10%
Our R&D shrinks while 0360.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-20.20%
We cut SG&A while 0360.HK invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.